A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
Saved in:
| Title: | A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC. |
|---|---|
| Authors: | Wu H; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Liu C; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Yuan Q; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Qiao Y; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Ding Y; Department of Pathophysiology, Shaoxing People Hospital, Shaoxing, China., Duan L; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Li W; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Zhang M; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Zhang X; The Affiliated Cancer Hospital, Zhengzhou University, Zhengzhou, China., Jiang Y; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Lu J; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Dong Z; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Wang T; Telethon Kids Institute, University of Western Australia, Perth, Australia.; The College of Nursing and Health, Zhengzhou University, Zhengzhou, China., Liu K; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China., Zhao J; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China. |
| Source: | Oncoimmunology [Oncoimmunology] 2023 Nov 27; Vol. 12 (1), pp. 2282250. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38126034 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Yuan+Q%22">Yuan Q</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Qiao+Y%22">Qiao Y</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Ding+Y%22">Ding Y</searchLink>; Department of Pathophysiology, Shaoxing People Hospital, Shaoxing, China.<br /><searchLink fieldCode="AU" term="%22Duan+L%22">Duan L</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; The Affiliated Cancer Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Dong+Z%22">Dong Z</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; Telethon Kids Institute, University of Western Australia, Perth, Australia.; The College of Nursing and Health, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2023 Nov 27; Vol. 12 (1), pp. 2282250. <i>Date of Electronic Publication: </i>2023 Nov 27 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38126034 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/2162402X.2023.2282250 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2282250 Titles: – TitleFull: A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu H – PersonEntity: Name: NameFull: Liu C – PersonEntity: Name: NameFull: Yuan Q – PersonEntity: Name: NameFull: Qiao Y – PersonEntity: Name: NameFull: Ding Y – PersonEntity: Name: NameFull: Duan L – PersonEntity: Name: NameFull: Li W – PersonEntity: Name: NameFull: Zhang M – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Jiang Y – PersonEntity: Name: NameFull: Lu J – PersonEntity: Name: NameFull: Dong Z – PersonEntity: Name: NameFull: Wang T – PersonEntity: Name: NameFull: Liu K – PersonEntity: Name: NameFull: Zhao J IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 11 Text: 2023 Nov 27 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2162-402X Numbering: – Type: volume Value: 12 – Type: issue Value: 1 Titles: – TitleFull: Oncoimmunology Type: main |
| ResultId | 1 |